Awakn Life Sciences to Participate at Upcoming March 2022 Conferences
Awakn Life Sciences Corp.(NEO: AWKN)(OTCMKTS: AWKNF), a biotechnology company, researching, developing and delivering psychedelic therapeutics to treat addiction, announced today that Anthony Tennyson, Awakn’s Chief Executive Officer, is scheduled to present at the following upcoming March 2022 investor conferences.
34th Annual ROTH Conference
Presentation: Sunday, March 13th to Tuesday, March 15th
Registration: Click here
Oppenheimer’s 32nd Annual Healthcare Conference
Presentation: Wednesday, March 15th to Thursday, March 17th
Registration: Please contact your Oppenheimer representation
Maxim’s 2022 Virtual Growth Conference
Presentation: Monday, March 28th to Wednesday, March 30th
Registration: Click here
For more information about each conference, or to schedule a one-on-one meeting with Awakn’s management team, please contact your ROTH, Oppenheimer or Maxim representatives, or alternatively KCSA Strategic Communications at [email protected].
To view the original press release in its entirety click here
